These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5561965)

  • 1. [A trial in treatment of gonorrhea with a sulphonamide with prolonged effect(sulfapherin)].
    Jorgensen BL
    Ugeskr Laeger; 1971 Jul; 133(26):1257-8. PubMed ID: 5561965
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of treatment of trachoma with vaccine and long-acting sulphonamide combinations compared with the vaccine and the sulphonamide alone.
    Guerra P; Aoky K; Buogo A
    Rev Int Trach; 1971; 47(1):23-30. PubMed ID: 5158068
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative evaluation of therapeutic efficacy of sulfamonomethoxin and sulfadimethoxin in patients with gonorrhea].
    Potapnev FV; Skuratovich AA
    Antibiotiki; 1973 May; 18(5):453-6. PubMed ID: 4781217
    [No Abstract]   [Full Text] [Related]  

  • 4. Evergreening: there's life in the old drug yet.
    Wyllie MG
    BJU Int; 2005 Jun; 95(9):1359-60. PubMed ID: 15892830
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness of treatment of gonorrhea with penicillin and its long-acting derivatives].
    Skuratovich AA; Anchupane IS; Afanas'ev BA; Bogdanova VN; Bragin OV
    Vestn Dermatol Venerol; 1981 Dec; (12):62-6. PubMed ID: 7331499
    [No Abstract]   [Full Text] [Related]  

  • 6. Why sulphonamides, when combined with 2-4-diamino-pyrimidines, are effective in sulphonamide-resistant gonorrhoea.
    Wright DJ
    Guys Hosp Rep; 1969; 118(2):287-91. PubMed ID: 5804069
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of an ultralong-acting sulphonamide (Fanasil) as a prophylactic agent.
    Stein H; Cohen H; Katze H; Goldberg J
    S Afr Med J; 1972 Sep; 46(38):1370. PubMed ID: 4638225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of leprosy by sulfones and delayed-action sulfonamides: comparison of therapeutic results in 100 cases].
    Privat Y; Faye I; Bellossi A
    Mars Med; 1968; 105(3):276-80. PubMed ID: 5754252
    [No Abstract]   [Full Text] [Related]  

  • 9. [Delayed-action sulfonamides: Fanasil. Comprehensive study].
    Leng-Lévy J; David-Chaussé J
    J Med Bord; 1966 May; 143(5):739-44. PubMed ID: 5943724
    [No Abstract]   [Full Text] [Related]  

  • 10. Warning against prolonged-action sulfonamides.
    Med Lett Drugs Ther; 1966 Feb; 8(4):13-4. PubMed ID: 5907884
    [No Abstract]   [Full Text] [Related]  

  • 11. [Considerations on plans for dosage of delayed-action sulfamides].
    Plancher AC; Salvi G; Strata A; Valdrè MV
    Clin Ter; 1967 Feb; 40(4):334-9. PubMed ID: 6077853
    [No Abstract]   [Full Text] [Related]  

  • 12. Sustained release of sulfamethizole from agar beads after oral administration to humans.
    Nakano M; Kouketsu M; Nakamura Y; Juni K
    Chem Pharm Bull (Tokyo); 1980 Oct; 28(10):2905-8. PubMed ID: 7448939
    [No Abstract]   [Full Text] [Related]  

  • 13. Multicenter trial of fleroxacin versus ceftriaxone in the treatment of uncomplicated gonorrhea.
    Smith BL; Mogabgab WJ; Dalu ZA; Jones RB; Douglas JM; Handsfield HH; Hook EW; Viner BL; Shands JW; McCormack WM
    Am J Med; 1993 Mar; 94(3A):81S-84S. PubMed ID: 8452187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfaethylthiadiazole (SETD) release from synthetic wax prolonged-release particles. I. Effect of dispersant concentration.
    Robinson IC; Becker CH
    J Pharm Sci; 1968 Jan; 57(1):49-53. PubMed ID: 5694995
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral treatment of gonorrhea and chlamydia.
    Loughlin KA; Bakst CM; Rybak MJ
    Ann Pharmacother; 1994 May; 28(5):600-2. PubMed ID: 8068998
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of amoxycillin, rifampicin and erythromycin in the single-dose peroral treatment of gonorrhea].
    Klíma J
    Cesk Dermatol; 1982 Aug; 57(4):224-31. PubMed ID: 7139733
    [No Abstract]   [Full Text] [Related]  

  • 17. [New slow-acting sulfonamide in the treatment of chronic asthma].
    Aguirre M; Lahoz F; Jiménez Casado M
    Rev Clin Esp; 1966 Jul; 102(2):105-8. PubMed ID: 5992358
    [No Abstract]   [Full Text] [Related]  

  • 18. [Indications for delayed-action sulfonamide therapy. Adverse effects and complications of sulfonamide therapy].
    Leng-Lévy J; Aubertin J; Leng B; Magendie P; Marion J
    J Med Bord; 1967 Oct; 144(10):1465-88. PubMed ID: 5605725
    [No Abstract]   [Full Text] [Related]  

  • 19. Injectable use may increase women's odds of getting chlamydia or gonorrhea.
    MacLean R
    Int Fam Plan Perspect; 2005 Mar; 31(1):45-6. PubMed ID: 15997501
    [No Abstract]   [Full Text] [Related]  

  • 20. [1,200 mg rifampicin(Rimactan) as an oral one-dose treatment of uncomplicated gonorrhea in women].
    Schwarzenbach HR; Rufli T; Glaus L; Bergamini N
    Dermatologica; 1983; 167(5):262-6. PubMed ID: 6653852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.